Literature DB >> 22410796

Is it the right time to subject children with acute kidney injury to rasburicase trials?

Tomasz Jarmoliński, Marcin Zaniew, Joanna Tousty, Dariusz Runowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22410796     DOI： 10.1007/s00467-012-2127-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Rasburicase in the treatment of hyperuricemia of newborns.

Authors:  Stefano Ghirardello; Gianluigi Ardissino; Antonio Mastrangelo; Fabio Mosca
Journal:  Pediatr Nephrol       Date:  2010-04-08       Impact factor: 3.714

2.  Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke.

Authors:  Pei-Yi Lin; Chun-Chen Lin; Hsi-Che Liu; Ming-Dar Lee; Hung-Chang Lee; Che-Sheng Ho; Nan-Chang Chiu; Chun-Chih Peng; Fu-Yuan Huang; Jeng-Daw Tsai
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

3.  Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases.

Authors:  Nakysa Hooman; Hasan Otukesh
Journal:  Iran J Kidney Dis       Date:  2011-03       Impact factor: 0.892

4.  Rasburicase for hyperuricemia in hemolytic uremic syndrome.

Authors:  Alisa A Acosta; Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2011-11-17       Impact factor: 3.714

5.  The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention.

Authors:  Sang-Ho Park; Won-Yong Shin; Eun-Young Lee; Hyo-Wook Gil; Se-Whan Lee; Seung-Jin Lee; Dong-Kyu Jin; Sae-Yong Hong
Journal:  Circ J       Date:  2011-01-14       Impact factor: 2.993

6.  Rasburicase improves hyperuricemia in infants with acute kidney injury.

Authors:  David J Hobbs; Julia M Steinke; Jin Y Chung; Gina-Marie Barletta; Timothy E Bunchman
Journal:  Pediatr Nephrol       Date:  2009-11-21       Impact factor: 3.714

7.  Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.

Authors:  André Bosly; Anne Sonet; C Ross Pinkerton; Geoffrey McCowage; Dominique Bron; Miguel A Sanz; Hendrik Van den Berg
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860
  7 in total
  1 in total

1.  Cyanosis in a male Nigerian infant with acute kidney injury: answers.

Authors:  Jasmin Pansy; Christoph J Mache; Gerfried Zobel; Gernot Grangl; Ekkehard Ring; K Martin Hoffmann
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.